Mennonite Christian Hospital 77th Anniversary Celebration
The CEO Ashley Yang was invited as a guest lecturer to share trends in iPSC applications.
MetaTech Biomed CEO, Ashley Yang, was invited to serve as a lecturer at Mennonite Christian Hospital’s 77th Anniversary Celebration, sharing the latest breakthroughs in neural disease repair and regenerative medicine, and joining domestic and international experts to explore the future of healthcare innovation.
Key Highlights
-
Global trends in regenerative medicine: Cancer and neurological diseases remain key focus areas worldwide
-
Breakthroughs in cell therapy: Both MSC (mesenchymal stem cells) and iPSC (induced pluripotent stem cells) demonstrate strong potential in repairing spinal cord injuries and neurodegenerative diseases
-
Emerging exosome therapies: Exosomes provide pro-angiogenic, neuroprotective, and immunomodulatory signals, creating new opportunities for stroke and neural injury treatment
-
Clinical progress: iPSC-derived dopaminergic neurons have entered clinical trials for Parkinson’s disease, demonstrating safety and improvements in motor function
-
Future outlook: By integrating regenerative cells, exosomes, and precision medicine, a “family-based regenerative medicine” model can be developed—bringing medical breakthroughs into everyday life
This event not only facilitated professional medical exchange, but also marked a new milestone in the transition of regenerative medicine toward clinical implementation and broader industry adoption. MetaTech Biomed will continue to advance its technologies and collaborate with experts across sectors to bring regenerative medicine benefits to more patients.
